Is a complete SNTI research report available?

No complete published report is available for Senti Biosciences Holdings, Inc. (SNTI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Senti Biosciences Holdings, Inc. (SNTI)

NASDAQ: SNTI · USD

$0.21

+0.03 (+14.3%)· Recorded snapshot

Market cap	6.6M
Revenue (ttm)	55K
Net income (ttm)	-49.6M
EPS (ttm)	-$1.71
Shares out	31.1M
Volume	9,538,750
Beta	2.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55K
Net income (ttm): -49.6M
EPS (ttm): -$1.71
Market cap: 6.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001854270
Company name	Senti Biosciences Holdings, Inc.
Country	United States
Country code	US
CUSIP number	816944102
Earnings date	2026-11-12
Earnings time	amc
Employees	39
Employees change	5
Employees growth	14.71%
Enterprise value	$20.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US8169441024
Last 10-K release date	2026-03-27
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-07-18
Last stock split type	Reverse
Market cap	$6.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.21
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	SNTI
U.S. state	California
Website	https://www.sentibio.com

Metric

Value

Amount currency

USD

CIK code

0001854270

Company name

Senti Biosciences Holdings, Inc.

Country

United States

Country code

CUSIP number

816944102

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

14.71%

Enterprise value

$20.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US8169441024

Last 10-K release date

2026-03-27

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2024-07-18

Last stock split type

Reverse

Market cap

$6.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$0.21

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

SNTI

U.S. state

California

Website

https://www.sentibio.com

Metric	Value
Earnings yield	-801.8%
EV/Sales	353.34x
FCF / EV yield	-195.8%
FCF yield	-654.39%
P/S ratio	105.72x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-801.8%

EV/Sales

353.34x

FCF / EV yield

-195.8%

FCF yield

-654.39%

P/S ratio

105.72x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Operating margin	-96,943.64%
Pretax margin	-90,116.36%
Profit per employee	$-1.3M
Revenue per employee	$1,410
ROA	-65.57%
ROA (5Y)	-33.95%
ROCE	-307.49%
ROE	-466.46%
ROE (5Y)	-113.56%
ROIC	-91.57%
SBC / revenue	9,707.27%

Metric

Value

Operating margin

-96,943.64%

Pretax margin

-90,116.36%

Profit per employee

$-1.3M

Revenue per employee

$1,410

ROA

-65.57%

ROA (5Y)

-33.95%

ROCE

-307.49%

ROE

-466.46%

ROE (5Y)

-113.56%

ROIC

-91.57%

SBC / revenue

9,707.27%

Metric	Value
EPS growth quarters	7
EPS growth years	4
Net income growth quarters	2
Net income growth years	0
Revenue growth (QoQ)	6.25%
Revenue growth 3Y	-76.14%
Revenue growth 5Y	-37.27%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth (QoQ)

6.25%

Revenue growth 3Y

-76.14%

Revenue growth 5Y

-37.27%

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$3.2M
EBIT	$-53.3M
EBITDA	$-50.2M
EPS	$-1.71
FCF per share	$-1.22
Financing cash flow	$20.7M
Free cash flow	$-38.1M
Free cash flow minus SBC	$-43.4M
Gross profit	$-31.3M
Investing cash flow	$114,000
Net borrowing	$9.7M
Net cash flow	$-17.2M
Net income	$-49.6M
Operating cash flow minus SBC	$-43.4M
Operating income	$-53.3M
Revenue	$55,000
Stock-based compensation	$5.3M

Metric

Value

Capital expenditures

Depreciation and amortization

$3.2M

EBIT

$-53.3M

EBITDA

$-50.2M

EPS

$-1.71

FCF per share

$-1.22

Financing cash flow

$20.7M

Free cash flow

$-38.1M

Free cash flow minus SBC

$-43.4M

Gross profit

$-31.3M

Investing cash flow

$114,000

Net borrowing

$9.7M

Net cash flow

$-17.2M

Net income

$-49.6M

Operating cash flow minus SBC

$-43.4M

Operating income

$-53.3M

Revenue

$55,000

Stock-based compensation

$5.3M

Metric	Value
Altman Z-Score	-20.69
Book value per share	$-0.11
Long-term assets	$20.1M
Long-term liabilities	$20.7M
Net cash (debt)	$-13.6M
Net cash / market cap	-234.22%
Piotroski F-Score	1
Property, plant and equipment	$18.7M
Shareholders' equity	$-3.4M
Tangible book value	$-3.4M
Tangible book value per share	$-0.11
Total assets	$33.1M
Total cash	$6.6M
Total debt	$20.2M
Total liabilities	$36.5M
WACC	3.67%

Metric

Value

Altman Z-Score

-20.69

Book value per share

$-0.11

Long-term assets

$20.1M

Long-term liabilities

$20.7M

Net cash (debt)

$-13.6M

Net cash / market cap

-234.22%

Piotroski F-Score

Property, plant and equipment

$18.7M

Shareholders' equity

$-3.4M

Tangible book value

$-3.4M

Tangible book value per share

$-0.11

Total assets

$33.1M

Total cash

$6.6M

Total debt

$20.2M

Total liabilities

$36.5M

WACC

3.67%

Metric	Value
Asset turnover	0
Current assets	$13M
Current liabilities	$15.8M
Current ratio	0.83
Net working capital	$-1.9M
Quick ratio	0.45
Working capital	$-2.8M
Working capital turnover	0.01

Metric

Value

Asset turnover

Current assets

$13M

Current liabilities

$15.8M

Current ratio

0.83

Net working capital

$-1.9M

Quick ratio

0.45

Working capital

$-2.8M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-155.08%
Dividend yield	0%
Shareholder yield	-155.08%

Metric

Value

Buyback yield / dilution

-155.08%

Dividend yield

Shareholder yield

-155.08%

Metric	Value
150-day SMA	$0.66
1D price change	14.3%
1M price change	-35.2%
1M total return	-35.2%
1W price change	-1.89%
1W total return	-1.89%
1Y price change	-90.47%
1Y return CAGR	-90.49%
1Y total return	-90.47%
20-day SMA	$0.26
200-day SMA	$0.73
3M price change	-42.88%
3M total return	-42.88%
3Y price change	-92.87%
3Y return CAGR	-58.53%
3Y total return	-92.87%
50-day SMA	$0.31
50-day SMA vs 200-day SMA	50under200
52-week high	$2.88
52-week high date	2025-12-09
52-week low	$0.16
52-week low date	2026-10-27
5Y price change	-99.79%
5Y return CAGR	-70.8%
5Y total return	-99.79%
6M price change	-79.87%
6M total return	-79.87%
All-time high	$105.40
All-time high date	2021-09-01
All-time low	$0.16
All-time low date	2026-10-27
Average true range (ATR)	$0.03
Average volume	9.7M
Beta (1Y)	2.74
Beta (2Y)	2.08
Beta (5Y)	2.22
Change from 52-week high	-92.59%
Change from 52-week low	36.8%
Change from all-time high	-99.8%
Change from all-time low	36.79%
Change from open	14.48%
Day's gap	-0.16%
Dollar volume	$2M
High price	$0.23
Low price	$0.18
Monthly RSI	28.27
Open price	$0.19
Position in 52-week range	64.98%
Premarket change	-0.32%
Premarket close	$0.19
Premarket price	$0.19
Premarket volume	3.3M
Previous close	$0.19
Price vs 150-day SMA	-67.56%
Price vs 20-day SMA	-18.05%
Price vs 200-day SMA	-70.89%
Price vs 50-day SMA	-31.03%
Relative volume	0.98
RSI	37.28
Sharpe ratio	-1.78
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.08
Sortino ratio	-2.12
Sortino ratio (3Y)	0.56
Sortino ratio (5Y)	-0.15
Volume	9.5M
Weekly RSI	28.88
YTD price change	-79.48%
YTD total return	-79.48%

Metric

Value

150-day SMA

$0.66

1D price change

14.3%

1M price change

-35.2%

1M total return

-35.2%

1W price change

-1.89%

1W total return

-1.89%

1Y price change

-90.47%

1Y return CAGR

-90.49%

1Y total return

-90.47%

20-day SMA

$0.26

200-day SMA

$0.73

3M price change

-42.88%

3M total return

-42.88%

3Y price change

-92.87%

3Y return CAGR

-58.53%

3Y total return

-92.87%

50-day SMA

$0.31

50-day SMA vs 200-day SMA

50under200

52-week high

$2.88

52-week high date

2025-12-09

52-week low

$0.16

52-week low date

2026-10-27

5Y price change

-99.79%

5Y return CAGR

-70.8%

5Y total return

-99.79%

6M price change

-79.87%

6M total return

-79.87%

All-time high

$105.40

All-time high date

2021-09-01

All-time low

$0.16

All-time low date

2026-10-27

Average true range (ATR)

$0.03

Average volume

9.7M

Beta (1Y)

2.74

Beta (2Y)

2.08

Beta (5Y)

2.22

Change from 52-week high

-92.59%

Change from 52-week low

36.8%

Change from all-time high

-99.8%

Change from all-time low

36.79%

Change from open

14.48%

Day's gap

-0.16%

Dollar volume

$2M

High price

$0.23

Low price

$0.18

Monthly RSI

28.27

Open price

$0.19

Position in 52-week range

64.98%

Premarket change

-0.32%

Premarket close

$0.19

Premarket price

$0.19

Premarket volume

3.3M

Previous close

$0.19

Price vs 150-day SMA

-67.56%

Price vs 20-day SMA

-18.05%

Price vs 200-day SMA

-70.89%

Price vs 50-day SMA

-31.03%

Relative volume

0.98

RSI

37.28

Sharpe ratio

-1.78

Sharpe ratio (3Y)

0.16

Sharpe ratio (5Y)

-0.08

Sortino ratio

-2.12

Sortino ratio (3Y)

0.56

Sortino ratio (5Y)

-0.15

Volume

9.5M

Weekly RSI

28.88

YTD price change

-79.48%

YTD total return

-79.48%

Metric	Value
Float	12M
Float percentage	38.53%
Shares change (QoQ)	0.56%
Shares change (YoY)	155.08%
Shares held by insiders	2.15%
Shares held by institutions	6.99%
Shares outstanding	31.1M
Short % of float	4.06%
Short % of shares	1.56%
Short ratio	0.5 days

Metric

Value

Float

12M

Float percentage

38.53%

Shares change (QoQ)

0.56%

Shares change (YoY)

155.08%

Shares held by insiders

2.15%

Shares held by institutions

6.99%

Shares outstanding

31.1M

Short % of float

4.06%

Short % of shares

1.56%

Short ratio

0.5 days

Senti Biosciences Holdings, Inc. (SNTI)

Price

Financial snapshot

Fair-value bridge

Latest news · SNTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNTI

Frequently asked questions